Rapid Test

Rapid Antigen Test

The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19. The Rapid Antigen test is to determine whether or not you are actively infected with the virus. The rapid COVID-19 antigen test detects specific proteins that are bound to the virus. Using a nasal swab to obtain a sample, antigen tests can produce accurate results in minutes. No need to run the sample to a lab or wait days for the result. Swab me now gets you results immediately.

Rapid Antibody Test

The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the SARS-CoV-2 in nasal, nasopharyngeal, and oropharyngeal swab samples from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to U.S. laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), to perform moderate and high complexity tests. The COVID-19 rapid antibody test only requires 15 minutes to check if you’ve been exposed to COVID-19 and have developed immunity. The test is conducted with patients who are experiencing symptoms of flu, cough and fever to get a more accurate result of whether it is the virus causing it or just a viral.


  1. Collect blood/serum/plasma sample.
  2. Add blood/serum/plasma sample to sample well.
  3. Place 2-3 drops of buffer in the machine.
  4. Read results after 10 minutes and no more than 15 minutes.

Machines used for conducting tests

The machine used for conducting tests is the BD Veritor™ System, which is slightly larger than a cell phone. It is currently in use at more than 25,000 hospitals, clinician offices, urgent care centers and retail pharmacies in all 50 U.S. states. Its one-button functionality, workflow flexibility, and ease-of-use make it an ideal solution for settings without laboratory personnel. It also offers customers real-time reporting capabilities through the BD Synapsys™ informatics solution providing them with the ability to easily report data for disease monitoring and surveillance purposes.

Conduction of our tests in detail

Collection and Handling of Samples

The handling of specimen collected while the Antigen test is conducted is the most important part to get accurate results. Delays from sample collection to testing should be minimized. Improper specimen collection may cause some swabs to have limited amounts of viral genetic or antigenic material for detection. Inadequate quality assurance procedures could result in cross contamination of the sample, which could cause inaccurate test results.

Performance of the Tests conducted

The tests performed by our machines are accurate by up to 99%. The rapid COVID-19 test gives our customer accurate results in under 13 minutes. The Rapid Antigen Test and The Rapid Antibody Test is conducted under strict supervision of our medical experts. Our happy customers are a proof of our incomparable performance. We offer a 30-mile radius coverage and our rapid response team will be at your place swiftly!

Results from Tests

The tests conducted is always examined prior to interpretation of patient results. We take every possible step to the control the provided are not valid, the patient results cannot be interpreted.

Examination and Interpretation of Patient Specimen Results

RP – all clinical samples should yield positive results for RP target at < 40 Ct. Samples that fail to show detection of RP and all three SARS-CoV-2 targets within this range should be repeated from extraction step. If sample detects any of the SARS-CoV-2 targets, the lack of amplification of RP target can be valid.

COVID-19 RT-PCR test Controls – Positive, Negative, and Internal

Negative (no template control) – negative for all targets detected (Ct Not Detected)

Positive – positive for all targets detected (Ct < 38)

Internal extraction (Hs_RPP30) – negative for SARS-CoV-2 targets (Ct Not Detected), positive for RNase P (RP) target (Ct < 40)

Negative extraction (NEC) – negative for SARS-CoV-2 targets (Ct Not Detected), positive for RNase P (RP) target (Ct < 40)

If any control does not perform as described above, run is considered invalid and all specimens are repeated from extraction step.

Hypothetical false positive rates based on prevalence